Published in Science on April 08, 1966
An approach to the mapping of antigens on the cell surface. Proc Natl Acad Sci U S A (1968) 3.46
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
The macromolecular properties of blood-group substances. Sedimentation-velocity and viscosity measurements. Biochem J (1967) 2.40
Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues. J Exp Med (1985) 2.37
Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun (1988) 2.06
Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut (1980) 2.04
Counterimmunoelectrophoresis of pneumococcal antigens:improved sensitivity for the detection of types VII and XIV. J Clin Microbiol (1975) 1.94
L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages. Proc Natl Acad Sci U S A (1981) 1.93
The structure and function of gastric mucus. Gut (1972) 1.75
Immunochemical studies on blood groups. XLI. Proposed structures for the carbohydrate portions of blood group A, B, H, Lewis-a, and Lewis-b substances. Proc Natl Acad Sci U S A (1968) 1.57
Isolation and characterization of the native glycoprotein from pig small-intestinal mucus. Biochem J (1981) 1.50
Solubilization and partial characterization of a phytohemagglutinin receptor site from human erythrocytes. Proc Natl Acad Sci U S A (1969) 1.47
The glycans of stem cells. Curr Opin Chem Biol (2007) 1.45
The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J Exp Med (1987) 1.38
Biosynthesis of intestinal mucins. Effect of puromycin on mucoprotein biosynthesis by sheep colonic mucosal tissue. Biochem J (1968) 1.38
Ecological studies of intestinal bacteria. Relation between the specificity of fecal ABO blood group antigen-degrading enzymes from enteric bacteria and the ABO blood group of the human host. J Clin Invest (1969) 1.26
An enzymatic basis for secretor status and blood group substance specificity in humans. Proc Natl Acad Sci U S A (1968) 1.24
Binding characteristics of lectins involved in the trapping of nematodes by fungi. Appl Environ Microbiol (1983) 1.13
ABO blood groups, secretor status, salivary protein, and serum and salivary immunoglobulin concentrations. Gut (1971) 1.09
The Ly-3 antigens on mouse thymocytes: immune precipitation and molecular weight characterization. J Exp Med (1976) 1.04
The release of radioactive nucleic acids and mucoproteins by trypsin and ethylenediaminetetra-acetate treatment of baby-hamster cells in tissue culture. Biochem J (1970) 0.98
Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status. Br J Cancer (1990) 0.96
Serological activity against galactosyl-alpha(1-3)galactose in sera from patients with several kinetoplastida infections. J Clin Microbiol (1988) 0.94
Age-related changes in chemical composition and physical properties of mucus glycoproteins from rat small intestine. Biochem J (1983) 0.90
Cell-surface mucosubstances from trypsin diaggregation of normal and virus-transformed lines of baby-hamster kidney cells. Biochem J (1973) 0.89
Identification of a defence mechanism in vivo against the leakage of enterokinase into the blood. Biochem J (1979) 0.89
Studies of the association of the A, B and Lewis Blood group antigens with carcinoembryonic antigen (CEA). Immunology (1974) 0.88
Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity. Glycoconj J (2001) 0.86
Studies on a Factor in Sweet Potato Root Which Agglutinates Spores of Ceratocystis fimbriata, Black Rot Fungus. Plant Physiol (1982) 0.86
The antigenicity of sequential polypetides. II. The antigenicity of some sequential polymers including several related to collagen. Immunology (1973) 0.83
Glycoprotein biosynthesis in small intestine. 3. Enzymatic basis for the difference in the antigenicity of mucins. J Clin Invest (1972) 0.82
Studies on a seminal plasma protein with blood group A specifity. Arch Dermatol Forsch (1972) 0.82
Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum. Sci Rep (2016) 0.81
The genetic control of histocompatibility iso-antigens. Immunology (1969) 0.81
Catfish antibodies to blood group substances. 3. Further studies with sera from fish injected with human group O secretor fluids. Immunology (1972) 0.80
Catfish antibodies to blood group substances. I. Response of the Australian freshwater catfish, Tandanus tandanus (Mitchell), to the injection of human A, B and H secretor materials. Immunology (1971) 0.80
Studies on the asymmetrically attached oligosaccharide of rabbit immunoglobulin-G. II. On the biological function of the C2-oligosaccharide. Immunology (1970) 0.80
Competition between serum IgG, IgM, and IgA anti-glycan antibodies. PLoS One (2015) 0.79
Subunit composition of human liver alpha-L-fucosidase. Biochem J (1979) 0.78
Blood group activities in water-soluble glycoproteins and in microsomal fractions of gastric mucosa in peptic ulcer and gastric cancer patients. Clin Exp Immunol (1969) 0.78
[ABO blood group expression in corneal allograft failures]. Ophthalmologe (2005) 0.78
Second Jenner international glycoimmunology meeting. Ann Rheum Dis (1992) 0.77
Imperial Cancer Research Fund British Association for Cancer Research. Joint symposium held at the Royal College of Surgeons, Lincolns Inn Fields, London 30 November--1 December 1978. Abstracts of papers. Br J Cancer (1979) 0.75
The blood groups of the Seneca Indians. Am J Hum Genet (1967) 0.75
On the function of the carbohydrate moieties of glycoproteins. Biochem J (1972) 0.75
Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies. J Cancer (2017) 0.75
Averting a malaria disaster. Lancet (1999) 9.40
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis (1997) 4.66
Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Trop Med Int Health (1999) 4.43
Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet (1990) 4.17
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol (2001) 3.84
Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem (1994) 3.34
Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol (1997) 2.77
Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother (2000) 2.68
Genetic and biochemical aspects of human blood-group A-, B-, H-, Le-a- and Le-b-specificity. Br Med Bull (1969) 2.20
Biochemistry and Genetics of the ABO, Lewis, and P blood group systems. Adv Hum Genet (1980) 2.08
Malarone-donation programme in Africa. Lancet (1997) 2.07
Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. J Infect Dis (2000) 2.06
Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am J Trop Med Hyg (1984) 1.99
An alpha-d-galactosyltransferase associated with the blood-group B character. Biochem J (1968) 1.95
A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil. J Pharm Pharmacol (1987) 1.95
Differential subcompartmentation of terminal glycosylation in the Golgi apparatus of intestinal absorptive and goblet cells. J Biol Chem (1986) 1.72
Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man. Br J Clin Pharmacol (1989) 1.71
Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet (1984) 1.61
The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. Br J Clin Pharmacol (1992) 1.53
The peptide moiety of human-blood-group active glycoproteins associated with the ABO and Lewis groups. Biochem J (1969) 1.49
Molecular and genetic aspects of human blood-group Le-b specificity. Nature (1967) 1.47
Low magnesium and phospholipid content of cell wals of Pseudomonas aeruginosa resistant to polymyxin. Nature (1970) 1.47
The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg (1997) 1.46
In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors. Am J Trop Med Hyg (1984) 1.42
Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS (1990) 1.40
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet (2002) 1.36
Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. Am J Trop Med Hyg (1991) 1.35
Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob Agents Chemother (1998) 1.34
Comparison of mosquito nets, proguanil hydrochloride, and placebo to prevent malaria. BMJ (1988) 1.31
The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. Am J Trop Med Hyg (2000) 1.28
An a-N-acetyl-D-galactosaminyltransferase associated with the human blood-group A character. Biochem J (1968) 1.26
Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Mol Biochem Parasitol (1985) 1.26
The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. Ann Trop Med Parasitol (1984) 1.25
A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya. Bull World Health Organ (1984) 1.23
In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs. Antimicrob Agents Chemother (1995) 1.21
Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine. Am J Trop Med Hyg (1995) 1.19
Relationship between structure, specificity and genes within the ABO and Lewis blood-group systems. Bibl Haematol (1965) 1.16
Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria. Antimicrob Agents Chemother (1997) 1.15
Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (1993) 1.11
Potent antimalarial activity of the alkaloid nitidine, isolated from a Kenyan herbal remedy. Antimicrob Agents Chemother (1995) 1.11
Isolectric points of the human blood group A-1, A-2 and B gene-associated glycosyltransferases in ovarian cyst fluids and serum. Biochem Biophys Res Commun (1975) 1.09
The action of the blood group B gene-specified -galactosyltransferase from human serum and stomach mucosal extracts on group O and 'Bombay' O h erythrocytes. Vox Sang (1972) 1.09
Measurement of halofantrine and its major metabolite desbutylhalofantrine in plasma and blood by high-performance liquid chromatography: a new methodology. J Chromatogr (1992) 1.08
Inadequacy of chlorproguanil 20 mg per week as chemoprophylaxis for falciparum malaria in Kenya. Lancet (1987) 1.06
Enzymes of Trichomonas foetus. Separation and properties of two beta-galactosidases. Biochem J (1970) 1.04
Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. Ann Trop Med Parasitol (1997) 1.04
Alpha-L-fucosyltransferases in human serum from donors of different ABO, secretor and Lewis blood-group phenotypes. Eur J Biochem (1972) 1.04
Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection. Int J Parasitol (2002) 1.01
Two alpha-3-D-galactosyltransferases in rabbit stomach mucosa with different acceptor substrate specificities. Eur J Biochem (1983) 1.00
Serologically active fucose-containing oligosaccharides isolated from human blood-group A and B substances. Nature (1965) 1.00
A blood group Sda-active pentasaccharide isolated from Tamm-Horsfall urinary glycoprotein. Biochem Biophys Res Commun (1983) 0.99
N-Acetyl-D-galactosaminyl-beta-(1 goes to 4)-d-galactose: a terminal non-reducing structure in human blood group Sda-active Tamm-Horsfall urinary glycoprotein. Biochem Biophys Res Commun (1982) 0.97
Alpha-L-fucosyltransferases in human submaxillary gland and stomach tissues associated with the H, Lea and Leb blood-group characters and ABH secretor status. Biochem Biophys Res Commun (1969) 0.97
'True' genotype of chimeric twins revealed by blood-group gene products in plasma. Vox Sang (1974) 0.97
Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialytransferase. Blood (1991) 0.96
Blood group gene specified glycosyltransferases in rare ABO groups and in leukaemia. Rev Fr Transfus Immunohematol (1978) 0.96
Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance. Trans R Soc Trop Med Hyg (1988) 0.94
Genetics and biochemistry of some human blood groups. Proc R Soc Lond B Biol Sci (1978) 0.93
Antimalarial activity in crude extracts of Malawian medicinal plants. Ann Trop Med Parasitol (1996) 0.93
Glycosyltransferases. Early history, development and future prospects. Carbohydr Res (1986) 0.93
Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium. Cancer Res (1988) 0.92
Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation. Gut (1991) 0.92
The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug. Am J Trop Med Hyg (1999) 0.90
A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children. Trans R Soc Trop Med Hyg (1990) 0.90
The nature of the human blood group P1 determinant. Biochem Biophys Res Commun (1974) 0.90
A survey of outpatient prescriptions dispensed in Kenyatta National Hospital. East Afr Med J (1980) 0.89
Glycosyl transferases in mammalian gastric mucosal linings. Biochem Biophys Res Commun (1967) 0.88
The relationship between the N-acetylgalactosamine content and the blood group Sda activity of Tamm and Horsfall urinary glycoprotein. Biochem Biophys Res Commun (1980) 0.88
Further observations on the Birmingham chimaera. J Med Genet (1976) 0.87
Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. Trans R Soc Trop Med Hyg (1995) 0.87
Human salivary fucosyltransferases : evidence for two distinct alpha-3-L-fucosyltransferase activities one or which is associated with the Lewis blood group Le gene. Biochem Biophys Res Commun (1981) 0.86
Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity. Glycoconj J (2001) 0.86
Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough. Trans R Soc Trop Med Hyg (1996) 0.86
In vitro response of Kenyan Plasmodium falciparum to chloroquine in different media. Trans R Soc Trop Med Hyg (1985) 0.85
The cis AB phenotype in three generations of one family: serological, enzymatic and cytogenetic studies. J Immunogenet (1978) 0.85
The peptide moiety of blood-group-specific glycoproteins. Some amino-acid sequences in the regions carrying the carbohydrate chains. Eur J Biochem (1974) 0.84
Tetracycline-sensitive polymyxin-resistant Pseudomonas aeruginosa. Lancet (1972) 0.84
Purification of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase from human milk: an enzyme transferring fucose primarily to type 1 and lactose-based oligosaccharide chains. Glycoconj J (1992) 0.83
-N-acetylgalactosaminyl- and -galactosyltransferases in human ovarian cyst epithelial linings and fluids. Biochem Biophys Res Commun (1972) 0.83
Efficacy of pyrimethamine/sulfadoxine in uncomplicated severe falciparum malaria in Kenya. Lancet (1990) 0.82
A single dose of intramuscular sulfadoxine-pyrimethamine as an adjunct to quinine in the treatment of severe malaria: pharmacokinetics and efficacy. Trans R Soc Trop Med Hyg (1993) 0.82
Studies on anti-folate antimalarials in east Africa. Parassitologia (1999) 0.81
The biosynthesis of blood group B determinants by the blood group A gene-specified alpha-3-N-acetyl-D-galactosaminyltransferase. Biochem Biophys Res Commun (1982) 0.81
Measurement of quinine in filter paper-absorbed blood by high-performance liquid chromatography. J Chromatogr (1991) 0.81
Leukemia-induced alterations of serum glycosyltransferase enzymes. Cancer Res (1980) 0.81
Binding properties of a blood group Le(a+) active sialoglycoprotein, purified from human ovarian cyst, with applied lectins. Biochim Biophys Acta (1996) 0.81
Antiprotozoal properties of 16,17-dihydrobrachycalyxolide from Vernonia brachycalyx. Planta Med (1998) 0.81
Structure, biosynthesis and genetics of the Sda antigen. Biochem Soc Trans (1987) 0.81
Reassessment of the acceptor specificity and general properties of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase purified from human milk. Glycoconj J (1992) 0.81
Inter-individual variation in the metabolic activation of the antimalarial biguanides. Parasitol Today (1991) 0.80
Genetic regulation of the structure of blood-group-specific glycoproteins. Biochem Soc Symp (1974) 0.80
Pharmacology and parasitology: integrating experimental methods and approaches to falciparum malaria. Br J Clin Pharmacol (1992) 0.80
Ferriprotoporphyrin catalysed decomposition of artemether: analytical and pharmacological implications. Biochem Pharmacol (1994) 0.80
Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya. Ann Trop Med Parasitol (1987) 0.80
Purification, properties and possible gene assignment of an alpha 1,3-fucosyltransferase expressed in human liver. Glycoconj J (1995) 0.79
Purification of the blood group H gene associated alpha-2-L-fucosyltransferase from human plasma. Glycoconj J (1990) 0.79
A malariometric survey in Turkana District, Kenya: chemosensitivity in vivo of Plasmodium falciparum infections and identity of the vector. Trans R Soc Trop Med Hyg (1996) 0.79
Characterisation of a blood-group A-active tetrasaccharide synthesised by a blood-group B gene-specified glycosyltransferase. Carbohydr Res (1984) 0.79
Enzymes involved in the biosynthesis of glycoconjugates. A UDP-2-acetamido-2-deoxy-D-glucose: beta-D-galactopyranosyl-(1 leads to 4)-saccharide (1 leads to 3)-2-acetamido-2-deoxy-beta-D- glucopyranosyltransferase in human serum. Carbohydr Res (1983) 0.79